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are subject to an Article Publication Fee. Immediately upon publication, all articles in EJC Supplements are made openly available
through the journal’s websites.
EJC Supplements will consider for publication the proceedings of scientific symposia, commissioned thematic issues, and collections of
invited articles on preclinical and basic cancer research, translational oncology, clinical oncology and cancer epidemiology and
prevention.
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EJC Supplements is an official journal of the European Organisation for Research and Treatment of Cancer (EORTC), the European
Association for Cancer Research (EACR), the European CanCer Organisation (ECCO) and the European Society of Breast Cancer
Specialists (EUSOMA).
For a full and complete Guide for Authors, please go to http://www.ejcancersupplements.com
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www.ejcancersupplements.com. For detailed instructions on the preparation of electronic artwork, please visit http://www.elsevier.
com/artworkinstructions. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will
be provided by the publisher. You can track accepted articles at http://www.elsevier.com/trackarticle. You can also check our Author
FAQs at http://www.elsevier.com/authorFAQ and/or contact Customer Support via http://support.elsevier.com.
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who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform
to correct scientific English may wish to use the English Language Editing service available from Elsevier’s WebShop http://
webshop.elsevier.com/languageediting/ or visit our customer support site http://support.elsevier.com for more information.
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